Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tommysdad who wrote (3787)	5/13/2001 11:12:46 PM
From: Jibacoa	Respond to of 52153

I agree that it is difficult to try to assign "value".<g> See the recent article from Dale Baker of the "50% investing" thread: streetsideinvestor.com <<Not designed to identify drug-like compounds, but to better design clinical trials and target drugs to those who may actually benefit.>> << Not really a "drug-discovery" technology, but more like a polling system for drugs.>> <<I don't think it is appropriate to value these two companies in a similar manner.>> Again, I agree that it is difficult to assign "value" and that "drug-discovery" or "polling systems for drugs" may be quite different to you while you try to assign "value" to each company, it makes no difference to me.<g> Bernard